Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (241-250 of 547) with videos related to

Pageof 55
Sort By:
BMC Research Notes|August 30, 2012
Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel diseaseRagam Attinkara, Jessica Mwinyi, Kaspar Truninger, et al.
Inflammatory Bowel Diseases|August 1, 2013
Effects of retinoids in mouse models of colitis: benefit or danger to the gastrointestinal tract?Isabelle Frey-Wagner, Anne Fischbeck, Alexandra Cee, et al.
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
International Journal of Epidemiology|January 29, 2019
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)Valérie Pittet, Pierre Michetti, Christoph Mueller, et al.
Digestion|July 31, 2014
Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendationsBernhard Sauter, Christoph Beglinger, Marc Girardin, et al.
Autophagy|August 9, 2017
PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent mannerMarianne R Spalinger, Silvia Lang, Claudia Gottier, et al.
Oncotarget|November 7, 2015
Mutant HRAS as novel target for MEK and mTOR inhibitorsMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 26, 2020
Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancerMatthias Sauter, Norbert Lombriser, Simon Bütikofer, et al.
BMC Cancer|June 23, 2010
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell linesLing Xu, Martin Hausmann, Wolfgang Dietmaier, et al.
Inflammatory Bowel Diseases|September 18, 2010
Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and stricturesJohannes K-H Meier, Michael Scharl, Sandra N Miller, et al.
Pageof 55

Showing results (241-250 of 547) with videos related to

Sort By:
Pageof 55
BMC Research Notes|August 30, 2012
Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel diseaseRagam Attinkara, Jessica Mwinyi, Kaspar Truninger, et al.
Inflammatory Bowel Diseases|August 1, 2013
Effects of retinoids in mouse models of colitis: benefit or danger to the gastrointestinal tract?Isabelle Frey-Wagner, Anne Fischbeck, Alexandra Cee, et al.
United European Gastroenterology Journal|November 18, 2020
Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurementsOrla Mader, Pascal Juillerat, Luc Biedermann, et al.
International Journal of Epidemiology|January 29, 2019
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)Valérie Pittet, Pierre Michetti, Christoph Mueller, et al.
Digestion|July 31, 2014
Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendationsBernhard Sauter, Christoph Beglinger, Marc Girardin, et al.
Autophagy|August 9, 2017
PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent mannerMarianne R Spalinger, Silvia Lang, Claudia Gottier, et al.
Oncotarget|November 7, 2015
Mutant HRAS as novel target for MEK and mTOR inhibitorsMichael K Kiessling, Alessandra Curioni-Fontecedro, Panagiotis Samaras, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 26, 2020
Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancerMatthias Sauter, Norbert Lombriser, Simon Bütikofer, et al.
BMC Cancer|June 23, 2010
Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell linesLing Xu, Martin Hausmann, Wolfgang Dietmaier, et al.
Inflammatory Bowel Diseases|September 18, 2010
Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and stricturesJohannes K-H Meier, Michael Scharl, Sandra N Miller, et al.
Pageof 55